219 related articles for article (PubMed ID: 8675602)
1. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of Bcl-X and reduced Bak in primary colorectal adenocarcinomas.
Krajewska M; Moss SF; Krajewski S; Song K; Holt PR; Reed JC
Cancer Res; 1996 May; 56(10):2422-7. PubMed ID: 8625322
[TBL] [Abstract][Full Text] [Related]
3. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
4. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
Branet F; Caron P; Camallières M; Selves J; Brousset P
Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
[TBL] [Abstract][Full Text] [Related]
5. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of Bcl-2, Bcl-X, Mcl-1, and Bax in tumors of central and peripheral nervous system origin.
Krajewski S; Krajewska M; Ehrmann J; Sikorska M; Lach B; Chatten J; Reed JC
Am J Pathol; 1997 Mar; 150(3):805-14. PubMed ID: 9060818
[TBL] [Abstract][Full Text] [Related]
7. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers.
Krajewska M; Krajewski S; Epstein JI; Shabaik A; Sauvageot J; Song K; Kitada S; Reed JC
Am J Pathol; 1996 May; 148(5):1567-76. PubMed ID: 8623925
[TBL] [Abstract][Full Text] [Related]
9. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma.
Chiappetta G; Tallini G; De Biasio MC; Manfioletti G; Martinez-Tello FJ; Pentimalli F; de Nigris F; Mastro A; Botti G; Fedele M; Berger N; Santoro M; Giancotti V; Fusco A
Cancer Res; 1998 Sep; 58(18):4193-8. PubMed ID: 9751634
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of Bcl-2, Bcl-x, and Bax in follicular carcinomas of the thyroid.
Haynik DM; Prayson RA
Appl Immunohistochem Mol Morphol; 2006 Dec; 14(4):417-21. PubMed ID: 17122638
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers.
Miyamoto Y; Hosotani R; Wada M; Lee JU; Koshiba T; Fujimoto K; Tsuji S; Nakajima S; Doi R; Kato M; Shimada Y; Imamura M
Oncology; 1999; 56(1):73-82. PubMed ID: 9885381
[TBL] [Abstract][Full Text] [Related]
12. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
[TBL] [Abstract][Full Text] [Related]
13. bcl2, p53 and bax in thyroid tumors and their relation to apoptosis.
Farid P; Gomb SZ; Péter I; Szende B
Neoplasma; 2001; 48(4):299-301. PubMed ID: 11712682
[TBL] [Abstract][Full Text] [Related]
14. Expression of apoptosis-related proteins in thyroid tumors and thyroid carcinoma cell lines.
Bröcker M; de Buhr I; Papageorgiou G; Schatz H; Derwahl M
Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():20-3. PubMed ID: 8980994
[TBL] [Abstract][Full Text] [Related]
15. Changes in the expression pattern of apoptotic molecules (galectin-3, Bcl-2, Bax, survivin) during progression of thyroid malignancy and their clinical significance.
Selemetjev SA; Savin SB; Paunovic IR; Tatic SB; Cvejic D
Wien Klin Wochenschr; 2015 May; 127(9-10):337-44. PubMed ID: 25471003
[TBL] [Abstract][Full Text] [Related]
16. [Expression of protooncogene bcl-2 in thyroid tumors].
Zhu J; Chen Y; Xue H
Zhonghua Yi Xue Za Zhi; 1996 Nov; 76(11):829-31. PubMed ID: 9275533
[TBL] [Abstract][Full Text] [Related]
17. Bcl-2 and Bax expression in thyroid tumours. An immunohistochemical and western blot analysis.
Manetto V; Lorenzini R; Cordon-Cardo C; Krajewski S; Rosai J; Reed JC; Eusebi V
Virchows Arch; 1997 Feb; 430(2):125-30. PubMed ID: 9083515
[TBL] [Abstract][Full Text] [Related]
18. Follicular, papillary, and "hybrid" carcinomas of the thyroid.
Castro P; Fonseca E; Magalhães J; Sobrinho-Simões M
Endocr Pathol; 2002; 13(4):313-20. PubMed ID: 12665649
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.
Zhao J; Leonard C; Brunner E; Gemsenjäger E; Heitz PU; Odermatt B
Int J Oncol; 2006 Nov; 29(5):1041-51. PubMed ID: 17016634
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and expression of apoptosis regulating proteins bcl-2, mcl-1, bcl-X, and bax in malignant mesothelioma.
Soini Y; Kinnula V; Kaarteenaho-Wiik R; Kurttila E; Linnainmaa K; Pääkkö P
Clin Cancer Res; 1999 Nov; 5(11):3508-15. PubMed ID: 10589765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]